Literature DB >> 9110176

The E6-Ap ubiquitin-protein ligase (UBE3A) gene is localized within a narrowed Angelman syndrome critical region.

J S Sutcliffe, Y H Jiang, R J Galijaard, T Matsuura, P Fang, T Kubota, S L Christian, J Bressler, B Cattanach, D H Ledbetter, A L Beaudet.   

Abstract

Angelman syndrome (AS) and Prader-Willi syndrome (PWS) are distinct clinical phenotypes resulting from maternal and paternal deficiencies, respectively, in human chromosome 15qll-q13. Although several imprinted, paternally expressed transcripts have been identified within the PWS candidate region, no maternally expressed gene has yet been identified within the AS candidate region. We have developed an integrated physical map spanning the PWS and AS candidate regions and localized two breakpoints, including a cryptic t(14;15) translocation associated with AS and a non-AS 15q deletion, which substantially narrow the AS candidate region to approximately 250 kb. Mapping data indicate that the entire transcriptional unit of the E6-AP ubiquitin-protein ligase (UBE3A) gene lies within the AS region. The UBE3A locus expresses a transcript of approximately 5 kb at low to moderate levels in all tissues tested. The mouse homolog of UBE3A was cloned and sequenced revealing a high degree of conservation at nucleotide and protein levels. Northern and RT-PCR analysis of Ube3a expression in mouse tissues from animals with segmental, paternal uniparental disomy failed to detect substantially reduced or absent expression compared to control animals, failing to provide any evidence for maternal-specific expression from this locus. Recent identification of de novo truncating mutations in UBE3A taken with these observations indicates that mutations in UBE3A can lead to AS and suggests that this locus may encode both imprinted and biallelically expressed products.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9110176      PMCID: PMC139148          DOI: 10.1101/gr.7.4.368

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  33 in total

1.  Angelman syndrome associated with a maternal 15q11-13 deletion of less than 200 kb.

Authors:  J L Buxton; C T Chan; H Gilbert; J Clayton-Smith; J Burn; M Pembrey; S Malcolm
Journal:  Hum Mol Genet       Date:  1994-08       Impact factor: 6.150

2.  Physical mapping studies at D15S10: implications for candidate gene identification in the Angelman syndrome/Prader-Willi syndrome chromosome region of 15q11-q13.

Authors:  T Woodage; R Lindeman; Z M Deng; A Fimmel; A Smith; R J Trent
Journal:  Genomics       Date:  1994-01-01       Impact factor: 5.736

3.  A complete YAC contig of the Prader-Willi/Angelman chromosome region (15q11-q13) and refined localization of the SNRPN gene.

Authors:  A Mutirangura; A Jayakumar; J S Sutcliffe; M Nakao; M J McKinney; K Buiting; B Horsthemke; A L Beaudet; A C Chinault; D H Ledbetter
Journal:  Genomics       Date:  1993-12       Impact factor: 5.736

4.  Imprinting mutations suggested by abnormal DNA methylation patterns in familial Angelman and Prader-Willi syndromes.

Authors:  A Reis; B Dittrich; V Greger; K Buiting; M Lalande; G Gillessen-Kaesbach; M Anvret; B Horsthemke
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

5.  Identification of a novel paternally expressed gene in the Prader-Willi syndrome region.

Authors:  R Wevrick; J A Kerns; U Francke
Journal:  Hum Mol Genet       Date:  1994-10       Impact factor: 6.150

6.  Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region.

Authors:  J S Sutcliffe; M Nakao; S Christian; K H Orstavik; N Tommerup; D H Ledbetter; A L Beaudet
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

7.  Maternal imprinting of human SNRPN, a gene deleted in Prader-Willi syndrome.

Authors:  M L Reed; S E Leff
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

8.  Functional imprinting and epigenetic modification of the human SNRPN gene.

Authors:  C C Glenn; K A Porter; M T Jong; R D Nicholls; D J Driscoll
Journal:  Hum Mol Genet       Date:  1993-12       Impact factor: 6.150

9.  Molecular definition of the Prader-Willi syndrome chromosome region and orientation of the SNRPN gene.

Authors:  K Buiting; B Dittrich; S Gross; V Greger; M Lalande; W Robinson; A Mutirangura; D Ledbetter; B Horsthemke
Journal:  Hum Mol Genet       Date:  1993-12       Impact factor: 6.150

10.  Imprinting analysis of three genes in the Prader-Willi/Angelman region: SNRPN, E6-associated protein, and PAR-2 (D15S225E).

Authors:  M Nakao; J S Sutcliffe; B Durtschi; A Mutirangura; D H Ledbetter; A L Beaudet
Journal:  Hum Mol Genet       Date:  1994-02       Impact factor: 6.150

View more
  48 in total

1.  Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome.

Authors:  Richard M Gustin; Terry Jo Bichell; Michael Bubser; Jennifer Daily; Irina Filonova; Davit Mrelashvili; Ariel Y Deutch; Roger J Colbran; Edwin J Weeber; Kevin F Haas
Journal:  Neurobiol Dis       Date:  2010-04-25       Impact factor: 5.996

2.  Ube3a imprinting impairs circadian robustness in Angelman syndrome models.

Authors:  Shu-qun Shi; Terry Jo Bichell; Rebecca A Ihrie; Carl Hirschie Johnson
Journal:  Curr Biol       Date:  2015-02-05       Impact factor: 10.834

3.  Genetic ablation of the steroid receptor coactivator-ubiquitin ligase, E6-AP, results in tissue-selective steroid hormone resistance and defects in reproduction.

Authors:  Carolyn L Smith; Darryll G DeVera; Dolores J Lamb; Zafar Nawaz; Yong-Hui Jiang; Arthur L Beaudet; Bert W O'Malley
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

Review 4.  Angelman Syndrome.

Authors:  Seth S Margolis; Gabrielle L Sell; Mark A Zbinden; Lynne M Bird
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

5.  The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily.

Authors:  Z Nawaz; D M Lonard; C L Smith; E Lev-Lehman; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

6.  Decreased Axon Caliber Underlies Loss of Fiber Tract Integrity, Disproportional Reductions in White Matter Volume, and Microcephaly in Angelman Syndrome Model Mice.

Authors:  Matthew C Judson; Alain C Burette; Courtney L Thaxton; Alaine L Pribisko; Mark D Shen; Ashley M Rumple; Wilmer A Del Cid; Beatriz Paniagua; Martin Styner; Richard J Weinberg; Benjamin D Philpot
Journal:  J Neurosci       Date:  2017-06-29       Impact factor: 6.167

7.  Reversal of impaired hippocampal long-term potentiation and contextual fear memory deficits in Angelman syndrome model mice by ErbB inhibitors.

Authors:  Hanoch Kaphzan; Pepe Hernandez; Joo In Jung; Kiriana K Cowansage; Katrin Deinhardt; Moses V Chao; Ted Abel; Eric Klann
Journal:  Biol Psychiatry       Date:  2012-03-03       Impact factor: 13.382

8.  Derangements of hippocampal calcium/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome.

Authors:  Edwin J Weeber; Yong-Hui Jiang; Ype Elgersma; Andrew W Varga; Yarimar Carrasquillo; Sarah E Brown; Jill M Christian; Banefsheh Mirnikjoo; Alcino Silva; Arthur L Beaudet; J David Sweatt
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

9.  E6AP in the brain: one protein, dual function, multiple diseases.

Authors:  Jimmy El Hokayem; Zafar Nawaz
Journal:  Mol Neurobiol       Date:  2013-10-05       Impact factor: 5.590

10.  Ube3a reinstatement mitigates epileptogenesis in Angelman syndrome model mice.

Authors:  Bin Gu; Kelly E Carstens; Matthew C Judson; Katherine A Dalton; Marie Rougié; Ellen P Clark; Serena M Dudek; Benjamin D Philpot
Journal:  J Clin Invest       Date:  2018-11-19       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.